Terms: = Head and neck cancer AND DNAJB1, HSPF1, 3337, ENSG00000132002, P25685, Hdj1, Hsp40 AND Treatment
8 results:
1. dnajb1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma.
Kirk AM; Crawford JC; Chou CH; Guy C; Pandey K; Kozlik T; Shah RK; Chung S; Nguyen P; Zhang X; Wang J; Bell M; Mettelman RC; Allen EK; Pogorelyy MV; Kim H; Minervina AA; Awad W; Bajracharya R; White T; Long D; Gordon B; Morrison M; Glazer ES; Murphy AJ; Jiang Y; Fitzpatrick EA; Yarchoan M; Sethupathy P; Croft NP; Purcell AW; Federico SM; Stewart E; Gottschalk S; Zamora AE; DeRenzo C; Strome SE; Thomas PG
Cell Rep Med; 2024 Mar; 5(3):101469. PubMed ID: 38508137
[TBL] [Abstract] [Full Text] [Related]
2. hsp40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-TCF3-MMP9 axis signaling.
Chen YS; Chang CW; Tsay YG; Huang LY; Wu YC; Cheng LH; Yang CC; Wu CH; Teo WH; Hung KF; Huang CY; Lee TC; Lo JF
Theranostics; 2018; 8(14):3841-3855. PubMed ID: 30083263
[TBL] [Abstract] [Full Text] [Related]
3. Targeting super-enhancer-associated oncogenes in oesophageal squamous cell carcinoma.
Jiang YY; Lin DC; Mayakonda A; Hazawa M; Ding LW; Chien WW; Xu L; Chen Y; Xiao JF; Senapedis W; Baloglu E; Kanojia D; Shang L; Xu X; Yang H; Tyner JW; Wang MR; Koeffler HP
Gut; 2017 Aug; 66(8):1358-1368. PubMed ID: 27196599
[TBL] [Abstract] [Full Text] [Related]
4. Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic antitumor effects.
Yoo JY; Hurwitz BS; Bolyard C; Yu JG; Zhang J; Selvendiran K; Rath KS; He S; Bailey Z; Eaves D; Cripe TP; Parris DS; Caligiuri MA; Yu J; Old M; Kaur B
Clin Cancer Res; 2014 Jul; 20(14):3787-98. PubMed ID: 24815720
[TBL] [Abstract] [Full Text] [Related]
5. [Clinical features of 39 children with head and neck rhabdomysarcoma in a single medical center, and treatment outcomes].
Zhang WL; Zhang Y; Huang DS; Guo F; Han T
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Nov; 14(11):847-51. PubMed ID: 23146733
[TBL] [Abstract] [Full Text] [Related]
6. Gene networks related to the cell death elicited by hyperthermia in human oral squamous cell carcinoma HSC-3 cells.
Tabuchi Y; Wada S; Furusawa Y; Ohtsuka K; Kondo T
Int J Mol Med; 2012 Mar; 29(3):380-6. PubMed ID: 22179328
[TBL] [Abstract] [Full Text] [Related]
7. Retrospective analysis on treating nasopharyngeal carcinoma with accelerated fractionation (6 fractions per week) in comparison with conventional fractionation (5 fractions per week): report on 3-year tumor control and normal tissue toxicity.
Lee AW; Sze WM; Yau TK; Yeung RM; Chappell R; Fowler JF
Radiother Oncol; 2001 Feb; 58(2):121-30. PubMed ID: 11166862
[TBL] [Abstract] [Full Text] [Related]
8. Brachytherapy for primary and recurrent nasopharyngeal carcinoma: 20 years' experience at Long Beach Memorial.
Syed AM; Puthawala AA; Damore SJ; Cherlow JM; Austin PA; Sposto R; Ramsinghani NS
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1311-21. PubMed ID: 10889385
[TBL] [Abstract] [Full Text] [Related]
